DK0656002T3 - 3-Oxo-pyrido(1,2-a)benzimidazol-4-carboxyl- og 4-oxo-azepino(1,2-a)benzimidazol-5-carboxylderivater, som er anvendelige ved - Google Patents

3-Oxo-pyrido(1,2-a)benzimidazol-4-carboxyl- og 4-oxo-azepino(1,2-a)benzimidazol-5-carboxylderivater, som er anvendelige ved

Info

Publication number
DK0656002T3
DK0656002T3 DK93920193T DK93920193T DK0656002T3 DK 0656002 T3 DK0656002 T3 DK 0656002T3 DK 93920193 T DK93920193 T DK 93920193T DK 93920193 T DK93920193 T DK 93920193T DK 0656002 T3 DK0656002 T3 DK 0656002T3
Authority
DK
Denmark
Prior art keywords
benzimidazole
oxo
pct
carboxyl
compounds
Prior art date
Application number
DK93920193T
Other languages
Danish (da)
English (en)
Inventor
Bruce E Maryanoff
David F Mccomsey
Ho Winston
Original Assignee
Mcneilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneilab Inc filed Critical Mcneilab Inc
Application granted granted Critical
Publication of DK0656002T3 publication Critical patent/DK0656002T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK93920193T 1992-08-19 1993-08-18 3-Oxo-pyrido(1,2-a)benzimidazol-4-carboxyl- og 4-oxo-azepino(1,2-a)benzimidazol-5-carboxylderivater, som er anvendelige ved DK0656002T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93217692A 1992-08-19 1992-08-19
PCT/US1993/007794 WO1994004532A1 (fr) 1992-08-19 1993-08-18 Derives de 3-oxo-pyrido(1,2-a^_)benzimidazole-4-carboxyle et de 4-oxo-azepino(1,2-a^_)benzimidazole-5-carboxyle utiles dans le traitement de maladies du systeme nerveux central

Publications (1)

Publication Number Publication Date
DK0656002T3 true DK0656002T3 (da) 2000-11-27

Family

ID=25461897

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93920193T DK0656002T3 (da) 1992-08-19 1993-08-18 3-Oxo-pyrido(1,2-a)benzimidazol-4-carboxyl- og 4-oxo-azepino(1,2-a)benzimidazol-5-carboxylderivater, som er anvendelige ved

Country Status (16)

Country Link
US (2) US5639760A (fr)
EP (1) EP0656002B1 (fr)
JP (1) JP3463935B2 (fr)
KR (1) KR100262762B1 (fr)
AT (1) ATE197455T1 (fr)
AU (1) AU679938B2 (fr)
BR (1) BR9306929A (fr)
CA (1) CA2142700C (fr)
DE (1) DE69329654T2 (fr)
DK (1) DK0656002T3 (fr)
ES (1) ES2153842T3 (fr)
GR (1) GR3035292T3 (fr)
HU (1) HU221369B1 (fr)
NZ (1) NZ255821A (fr)
PT (1) PT656002E (fr)
WO (1) WO1994004532A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI0935598T1 (en) * 1996-10-07 2004-04-30 Ortho-Mcneil Pharmaceutical, Inc. 5-HETEROATOM-CONTAINING ALKYL SUBSTITUTED-3-OXO-PYRIDO(1,2-a) BENZIMIDAZOLE-4-CARBOXAMIDE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS
ES2212081T3 (es) * 1996-10-07 2004-07-16 Ortho-Mcneil Pharmaceutical, Inc. Derivados de 3-oxo-pirido(1,2-a)bencimidazol-4-carboxamida que contienen 5-heteroatomos sustituidos con alquilo en el tratamiento de trastornos del sistema nervioso central.
US5922731A (en) * 1997-06-30 1999-07-13 Ortho Pharmaceutical Corporation 5- (heteroaryl)alkyl!-3-oxo-pyrido 1,2-a!benzimidazole-4-carboxamide derivatives useful in treating central nervous system disorders
AU2003204221B2 (en) * 1997-10-07 2006-07-27 Ortho-Mcneil Pharmaceutical, Inc. Dipyridoimidazolderivatives useful in treating central nervous system disorders
CA2305342A1 (fr) * 1997-10-07 1999-04-15 Ortho-Mcneil Pharmaceutical, Inc. Nouveaux derives heterocycliques utiles pour le traitement de troubles du systeme nerveux central
ES2190112T3 (es) * 1997-10-07 2003-07-16 Ortho Mcneil Pharm Inc Derivados de naftoimidazo (1-2)piridina, su preparacion y su utilizacion para el tratamiento de trastornos del sistema nervioso central.
AU2653499A (en) * 1998-02-04 1999-08-23 Neurogen Corporation Oxo-dipyridoimidazole-carboxamides: gaba brain receptor ligands
US6177569B1 (en) 1998-08-25 2001-01-23 Neurogen Corporation Oxo-pyridoimidazole-carboxamides: GABA brain receptor ligands
EP1107966B1 (fr) * 1998-08-25 2005-07-27 Neurogen Corporation Oxo-pyridoimidazole-carboxamides: ligands du recepteur cerebral gaba
AU4818000A (en) * 1999-05-06 2000-11-21 Neurogen Corporation Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands
WO2001009132A1 (fr) * 1999-08-02 2001-02-08 Ortho-Mcneil Pharmaceutical, Inc. DERIVES DE PYRIDO[1,2-a]BENZIMIDAZOLE SUBSTITUES EN C-6 UTILES DANS LE TRAITEMENT DES TROUBLES DU SYSTEME NERVEUX CENTRAL
GB0203058D0 (en) 2002-02-09 2002-03-27 Bp Chem Int Ltd Production of olefins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663934B1 (fr) * 1990-06-27 1994-06-03 Adir Nouveaux derives de l'acide 4 - amino butyrique, leur procede de preparation et les preparations pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
EP0656002B1 (fr) 2000-11-08
AU679938B2 (en) 1997-07-17
ATE197455T1 (de) 2000-11-11
US5639760A (en) 1997-06-17
WO1994004532A1 (fr) 1994-03-03
CA2142700A1 (fr) 1994-03-03
NZ255821A (en) 1996-10-28
PT656002E (pt) 2001-02-28
ES2153842T3 (es) 2001-03-16
HUT72654A (en) 1996-05-28
DE69329654T2 (de) 2001-03-15
US6218384B1 (en) 2001-04-17
AU5080893A (en) 1994-03-15
HU221369B1 (en) 2002-09-28
HU9500476D0 (en) 1995-04-28
GR3035292T3 (en) 2001-04-30
JP3463935B2 (ja) 2003-11-05
EP0656002A1 (fr) 1995-06-07
CA2142700C (fr) 2007-01-09
DE69329654D1 (de) 2000-12-14
BR9306929A (pt) 1999-01-12
KR100262762B1 (ko) 2000-08-01
JPH08500594A (ja) 1996-01-23

Similar Documents

Publication Publication Date Title
EE200000042A (et) Uued ühendid
DK0656002T3 (da) 3-Oxo-pyrido(1,2-a)benzimidazol-4-carboxyl- og 4-oxo-azepino(1,2-a)benzimidazol-5-carboxylderivater, som er anvendelige ved
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
ATE216390T1 (de) Neue verbindungen
GEP20033081B (en) Pharmaceutical Agents for Treatment of Parkinson's Disease, ADFD and Microadenomas
ES2134929T3 (es) Derivados de pirrolo-piridina como ligandos para receptores de dopamina.
SE9702563D0 (sv) Compounds
FI19992038A (fi) Menetelmä atsepinonien valmistamiseksi
NO953353L (no) Xantinderivater som adenosin-A -reseptorantagonister
IS4367A (is) CCK eða gastrín temprandi 5-heterósýklísk-1,5-bensódíazepín
ATE216891T1 (de) Verwendung von immunosuppressiva zur behandlung der schizophrenie
DK0648117T3 (da) Lægemiddel til at forebygge udvikling af tolerance ved behandling med benzodiazepin-receptor-bindende aktive forbindelser
MX9703288A (es) Oxazolil- y tiazolilimidazo-benzo- y tienodiacepinas y su uso como medicamentos.
ATE112256T1 (de) 9-amino-2-phenylbicyclo(3.3.1>nonane und 9-amino- 2-phenylbicyclo(3.3.1>-non-2-ene und diese enthaltende therapeutische mittel.
SE9301831D0 (sv) Pharmaceutical compositions
DK0691846T3 (da) Imidazoquinoxalinoner til behandling af sygdomme i centralnervesystemet